Analysis of the efficacy of the peppermint oil (Mentha piperita L.) on irritable bowel syndrome: an evidence-based review

• Autor(a) principal: Gomes, Joana Costa
• Data de Publicação: 2013
• Outros Autores: Silva, Filipa
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Brasileira de Medicina de Família e Comunidade (Online)
• Texto Completo: https://www.rbmfc.org.br/rbmfc/article/view/702
• topic: Irritable Bowel Syndrome; Peppermint Oil; Phytotherapy; Plant Preparations; Síndrome del Colon Irritable; Aceite de Menta; Fitoterapia; Preparados de Plantas; Síndrome do Intestino Irritável; Óleo de Hortelã-pimenta; Fitoterapia; Preparações de Plantas; Terapêutica

Objective: To evaluate the efficacy of peppermint oil (Mentha piperita L.) on individuals diagnosed with irritable bowel syndrome (IBS) regarding symptom improvement and quality of life enhancement. Methods: Literature search was conducted according to evidence based on methodology review at Trip database, National Guideline Clearinghouse, Guidelines finder, Cochrane Library, Dare, Bandolier and Medline, as well as using the MeSH index terms “Irritable bowel syndrome” and “peppermint oil”. We selected practice guidelines, systematic reviews, meta-analysis and randomized controlled trials that evaluated peppermint oil (PO) efficacy in improving symptoms and/or quality of life when compared to placebo or other approved therapy for IBS. Results and Discussion: A total of eight articles were selected including five practice guidelines and three systematic reviews/ meta-analysis. Existing evidence suggests that there are enough data to support the use of peppermint oil in IBS for overall symptomatic relief, especially when abdominal pain is the dominant symptom, when compared to placebo (with an odds ratio of 2.7; CI 95%, 1.6 to 4.8 and NNT of 3). There is also evidence regarding overall quality of life improvement when using PO compared to placebo (p<0.001). Conclusion: So far, evidence suggests that PO should be considered for IBS patients, especially in the presence of abdominal pain (Strength of recommendation B). However, more high methodological quality studies that evaluate long-term efficacy and security of PO are needed.